Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROCKET PHARMACEUTICALS, INC. Director's Dealing 2015

Nov 19, 2015

33148_dirs_2015-11-18_363d0806-63fd-47aa-aa9f-c5f0ff78574b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-11-16

Reporting Person: Rho Ventures IV Holdings LLC (10% Owner)
Reporting Person: Rho Ventures IV-A, L.P. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-16 Common Stock J 115083 Disposed 636496 Direct
2015-11-16 Common Stock J 127711 Disposed 0 Direct

Footnotes

F1: On November 16, 2015, Rho Ventures IV Holdings LLC ("RV IV Holdings") distributed, for no consideration, 115,083 shares of Common Stock of the Issuer to one or more of its members. The distribution was made in accordance with the exemption afforded by Rule 16a-13 of the Securities Exchange Act of 1934, as amended.

F2: Shares are held by RV IV Holdings

F3: On November 16, 2015, Rho Ventures IV-A, L.P. ("RV IV-A") distributed, for no consideration, 127,711 shares of Common Stock of the Issuer to one or more of its partners. The distribution was made in accordance with the exemption afforded by Rule 16a-13 of the Securities Exchange Act of 1934, as amended.

F4: RV IV-A no longer holds any shares of the Issuer.